Ardelyx Inc. Common Stock (ARDX)
Stock · NASDAQ · Health Care
$3.81as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$6.04
Industry
Biotechnology: Pharmaceutical Preparations
About ARDX
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, I…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 489
- Website
- www.ardelyx.com/
Fundamentals
- 1-day range
- $3.93$4.27
- Market cap
- $1.20B
- P/E (trailing)
- —
- P/E (forward)
- 12.53
- EPS (trailing)
- $-0.23
- Dividend yield
- —
- Beta
- 0.63
- Avg. volume
- 3.84M
52-week range
$3.73$8.4
Next earnings: October 29, 2026 · EPS estimate $-0.01confirmed
How Ardelyx Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 19, 2026 · via SEC EDGAR / Finnhub
Forecasts
10 analyst ratings
Buy 94%
Hold 6%
Sell 0%
1-year price forecast
High
$18
+372.4%
Median
$13.5
+254.3%
Low
$8
+110.0%
Ardelyx Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ARDXArdelyx Inc. Common Stock$3.81▼ 0.26%Market cap $1.20BP/E —$3.73$8.4
- SVRASavara Inc. Common Stock$5.27▼ 4.10%Market cap $1.19BP/E —$3.19$7.01
- WVEWave Life Sciences Ltd. Ordinary Shares$5.04▼ 2.33%Market cap $1.19BP/E —$5.01$21.73
- SPTXSeaport Therapeutics Inc. Common Stock$24.04▼ 8.42%Market cap $1.24BP/E —$14.85$28.38
- CRVSCorvus Pharmaceuticals Inc. Common Stock$14.15▼ 3.87%Market cap $1.17BP/E —$5.28$26.95
- MNKDMannKind Corporation Common Stock$3.96▼ 2.59%Market cap $1.24BP/E —$2.23$6.51
- ETONEton Pharmaceuticals Inc. Common Stock$59.79▼ 4.60%Market cap $1.26BP/E —$14.27$66.37
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ARDX Ardelyx Inc. Common Stock | $1.20B | — | $3.81 | ▼ 0.26% | $3.73$8.4 |
| SVRA Savara Inc. Common Stock | $1.19B | — | $5.27 | ▼ 4.10% | $3.19$7.01 |
| WVE Wave Life Sciences Ltd. Ordinary Shares | $1.19B | — | $5.04 | ▼ 2.33% | $5.01$21.73 |
| SPTX Seaport Therapeutics Inc. Common Stock | $1.24B | — | $24.04 | ▼ 8.42% | $14.85$28.38 |
| CRVS Corvus Pharmaceuticals Inc. Common Stock | $1.17B | — | $14.15 | ▼ 3.87% | $5.28$26.95 |
| MNKD MannKind Corporation Common Stock | $1.24B | — | $3.96 | ▼ 2.59% | $2.23$6.51 |
| ETON Eton Pharmaceuticals Inc. Common Stock | $1.26B | — | $59.79 | ▼ 4.60% | $14.27$66.37 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Wedbush Reiterates Outperform on Ardelyx, Maintains $9 Price Targetbenzinga · 8/19/2026
- Wedbush Reiterates Outperform on Ardelyx, Maintains $9 Price TargetBenzinga · 8/19/2026
- Piper Sandler Maintains Overweight on Ardelyx, Lowers Price Target to $15Benzinga · 8/17/2026
- Ardelyx Q2: Strong Demand, But Payer Friction Clouds The StorySeekingAlpha · 8/12/2026
- Citigroup Maintains Buy on Ardelyx, Lowers Price Target to $11Benzinga · 8/10/2026
- TD Cowen Maintains Buy on Ardelyx, Lowers Price Target to $10Benzinga · 8/7/2026
- Ardelyx, Inc. (ARDX) Q2 2026 Earnings Call TranscriptSeekingAlpha · 8/7/2026
- BTIG Maintains Buy on Ardelyx, Lowers Price Target to $14Benzinga · 8/7/2026
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga · 8/7/2026
Insider Activity
Insider Actions →Acquired
0
Disposed
47.7K
- Hohenleitner Susan · August 21, 2026 · Sale1.6K @ $3.86
- Brady James Parker · August 21, 2026 · Sale13.2K @ $3.86
- Brady James Parker · August 21, 2026 · Sale2.0K @ $3.86
- Reilly Joseph James · August 21, 2026 · Sale1.1K @ $3.86
- Reilly Joseph James · August 21, 2026 · Sale2.9K @ $3.86
- Foster Eric Duane · August 21, 2026 · Sale2.6K @ $3.86
- Foster Eric Duane · August 21, 2026 · Sale3.4K @ $3.86
- Foster Eric Duane · August 21, 2026 · Sale2.6K @ $3.86
- Kelliher Mike · August 21, 2026 · Sale2.0K @ $3.86
- Kelliher Mike · August 21, 2026 · Sale2.7K @ $3.86
- Kelliher Mike · August 21, 2026 · Sale3.1K @ $3.86
- Williams Laura A · August 21, 2026 · Sale1.7K @ $3.86
- Williams Laura A · August 21, 2026 · Sale2.4K @ $3.86
- Williams Laura A · August 21, 2026 · Sale3.1K @ $3.86
- Williams Laura A · August 21, 2026 · Sale3.5K @ $3.86
Institutional Ownership
March 31, 2026
- Total shares held
- 162.33M
- Total value held
- $957.69M
- Institutional holders
- 230
Top holders this quarter
- Unknown21.16M
- Unknown18.04M
- Unknown13.60M
- Unknown10.37M
- Unknown8.37M
- Unknown8.17M
- Unknown6.01M
- Unknown5.23M
- Unknown4.27M
- Unknown3.76M
See the full, filterable feed with live charts on the MarketWall dashboard.